The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 13,979 | 244,950 | SH | SOLE | 244,950 | 0 | 0 | ||
ABBVIE INC | COM | 00287Y109 | 72,475 | 749,410 | SH | SOLE | 749,410 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 134,954 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 71,144 | 316,180 | SH | SOLE | 316,180 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 111,504 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
BIOVERATIV INC | COM | 09075E100 | 202,200 | 3,750,000 | SH | SOLE | 3,750,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 9,119 | 367,832 | SH | SOLE | 367,832 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 24,798 | 404,670 | SH | SOLE | 404,670 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 180,021 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 66,221 | 973,840 | SH | SOLE | 973,840 | 0 | 0 | ||
CORINDUS VASCULAR ROBOTICS I | COM | 218730109 | 20,181 | 19,981,655 | SH | SOLE | 19,981,655 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 81,563 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | ||
DANAHER CORP DEL | COM | 235851102 | 11,571 | 124,660 | SH | SOLE | 124,660 | 0 | 0 | ||
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 2,214 | 101,000 | SH | SOLE | 101,000 | 0 | 0 | ||
HAEMONETICS CORP | COM | 405024100 | 84,216 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 65,352 | 263,440 | SH | SOLE | 263,440 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 127,859 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 80,823 | 221,470 | SH | SOLE | 221,470 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 76,693 | 783,380 | SH | SOLE | 783,380 | 0 | 0 | ||
JOHNSON & JOHNSON | COM | 478160104 | 27,191 | 194,610 | SH | SOLE | 194,610 | 0 | 0 | ||
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 175,461 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 49,790 | 622,997 | SH | SOLE | 622,997 | 0 | 0 | ||
MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 6,416 | 284,400 | SH | SOLE | 284,400 | 0 | 0 | ||
MEDNAX INC | COM | 58502B106 | 67,421 | 1,261,620 | SH | SOLE | 1,261,620 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 157,463 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 219,453 | 3,900,000 | SH | SOLE | 3,900,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 118,325 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 127,820 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 122,187 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 72,886 | 1,309,960 | SH | SOLE | 1,309,960 | 0 | 0 | ||
STRYKER CORP | COM | 863667101 | 25,747 | 166,280 | SH | SOLE | 166,280 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 44,818 | 2,956,351 | SH | SOLE | 2,956,351 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 69,445 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 108,649 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 12,067 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 184,022 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
ZOETIS INC | CL A | 98978V103 | 46,473 | 645,100 | SH | SOLE | 645,100 | 0 | 0 |